Compare VANI & ZBAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VANI | ZBAI |
|---|---|---|
| Founded | 1998 | 2015 |
| Country | United States | United States |
| Employees | N/A | 6 |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Professional Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 95.8M | 95.5M |
| IPO Year | 2014 | N/A |
| Metric | VANI | ZBAI |
|---|---|---|
| Price | $1.14 | $8.20 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $3.50 | N/A |
| AVG Volume (30 Days) | ★ 288.1K | 3.4K |
| Earning Date | 05-14-2026 | 06-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $4,000,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.92 | $0.30 |
| 52 Week High | $1.92 | $11.94 |
| Indicator | VANI | ZBAI |
|---|---|---|
| Relative Strength Index (RSI) | 41.16 | 54.19 |
| Support Level | $1.08 | $7.34 |
| Resistance Level | $1.55 | $8.50 |
| Average True Range (ATR) | 0.08 | 0.63 |
| MACD | -0.03 | -0.05 |
| Stochastic Oscillator | 1.35 | 46.76 |
Vivani Medical Inc is a preclinical-stage biopharmaceutical company. The company develops miniaturized, subdermal implants utilizing its proprietary NanoPortal technology to enable long-term, near-constant-rate delivery of a broad range of medicines to treat chronic diseases. It has two reporting segments, the Biopharm Division and the Neuromodulation Division. The Biopharm Division includes activities from NPM and Vivani Medical Australia Pty Ltd, and the Neurostimulation Division includes activities from Cortigent and its subsidiary in Switzerland.
ATIF Holdings Ltd is a consulting company. It provides financial consulting services to small and medium-sized enterprises. It operates in one operating segment, which is the consulting service business. The company prominently generated revenues from consulting services to its clients. Geographically, the maximum revenue is derived from Hong Kong.